Medtronic

Medtronic to acquire China Kanghui Holdings

Friday, September 28, 2012 02:32 PM

Medtronic, a global medical technology company based in Minneapolis, Minn., has agreed to acquire China Kanghui Holdings for approximately $816 million in cash ($30.75 per American depository share). The total value of the transaction, net of Kanghui's cash, is expected to be approximately $755 million.

More... »

Medtronic establishes Shanghai Innovation Center

Wednesday, August 29, 2012 10:54 AM

Medtronic, a global medical technology company based in Minneapolis, Minn., has officially opened its Innovation Center in Shanghai, China.

More... »

VisionCare closes financing, makes board changes

Tuesday, January 24, 2012 12:51 PM

VisionCare Ophthalmic Technologies, a developer of advanced visual prosthetic devices, will close a Series E financing with Agate Medical Investments leading the expansion round.  Agate's managing general partner, Chanan Schneider, will join the VisionCare team as a board observer.

More... »

Report: U.S. medical innovation at risk without funding

Thursday, October 6, 2011 12:03 PM

U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investment away from the United States towards Europe and Asia, according to a report by the National Venture Capital Association'sMedIC Coalition.

More... »

Medical Device Consultants names senior regulatory consultant

Wednesday, July 20, 2011 11:55 AM

Medical Device Consultants has named Brian Edwards senior regulatory staff consultant of its regulatory services group. He will be based in Minneapolis, Minn., where he will support clients with U.S. FDA and international medical device submissions.

More... »

Medtronic appoints Omar Ishrak as chairman and CEO

Wednesday, May 11, 2011 11:59 AM

Medtronic’s board of directors named Omar Ishrak as the company's new chairman and chief executive officer.

More... »

Lilly and Medtronic to collaborate on Parkinson’s research

Tuesday, April 26, 2011 01:11 PM

Eli Lilly and Medtronic will collaborate to research and develop a new approach to treating Parkinson's disease.  The new approach involves investigating the delivery of a new medicine to the brain using an implantable drug delivery system. The goal is to develop a therapeutic approach to treating Parkinson's disease that combines Lilly's biologic, a modified form of glial cell derived neurotrophic factor (GDNF), with Medtronic's implantable drug infusion system technology.

More... »

MAP Pharmaceuticals names Scott R. Ward board of directors chairman

Tuesday, March 1, 2011 08:00 AM

MAP Pharmaceuticals has named Scott R. Ward chairman of its Board of Directors. Current Chairman Steven A. Elms will step down from the board after more than six years of service.

More... »